NCT00600353View on ClinicalTrials.gov

Multi-day Doses in Prevention of Nausea and Emesis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Myeloma, Plasma-CellLymphoma, Malignant
Interventions
DRUG

Palonosetron

Palonosetron 0.25 mg IV over 30 seconds

DRUG

Aprepitant

Aprepitant 125 mg PO and Aprepitant 80 mg PO

DRUG

Dexamethasone

Dexamethasone 4 mg IV and Dexamethasone 4 mg IV push

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

Eisai Inc.

INDUSTRY

lead

University of Kansas Medical Center

OTHER

NCT00600353 - Multi-day Doses in Prevention of Nausea and Emesis | Biotech Hunter | Biotech Hunter